AstraZeneca bets $1 billion on revolutionary cancer therapy
The Guardian - 17-Mar-2025AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
Join the club for FREE to access the whole archive and other member benefits.
AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
DNase I improved CAR T cell impact and survival in a melanoma model
Collaboration aims to develop advanced CAR T-cell treatments for solid tumours
No resources found!
No blog posts found!